LAG3 Marks Activated but Hyporesponsive NK Cells

Valeria Vasilyeva(University of Ottawa), Olivia Makinson(University of Ottawa), Cynthia Chan(University of Ottawa), M. Park(University of Ottawa), Colin O’Dwyer(University of Ottawa), Ayad Ali(Cincinnati Children's Hospital Medical Center), Abrar Ul Haq Khan(University of Ottawa), Christiano Tanese de Souza(Ottawa Hospital), Mohamed S. Hasim(University of Ottawa), Sara Asif(University of Ottawa), Reem Kurdieh(University of Ottawa), John Abou‐Hamad(University of Ottawa), Edward Yakubovich(University of Ottawa), Jonathan J. Hodgins(University of Ottawa), Patrick Haddad(University of Ottawa), Giuseppe Pietropaolo(Istituto Neurologico Mediterraneo), Julija Mazej(Istituto Pasteur), Hobin Seo(University of Calgary), Qiutong Huang(University of Calgary), Sarah Nersesian(University of Ottawa), Damien Chay(Réseau pour la Transition Énergétique), Nicolas Jacquelot(University of Calgary), David P. Cook(University of Ottawa), SeungHwan Lee(University of Ottawa), Giuseppe Sciumè(Istituto Pasteur), Stephen N. Waggoner(Cincinnati Children's Hospital Medical Center), Michele Ardolino(University of Ottawa), Marie Marotel(University of Ottawa)
European Journal of Immunology
July 1, 2025
Cited by 5Open Access
Full Text

Abstract

NK cells are critical for immunosurveillance, yet become dysfunctional when chronically stimulated by virally infected or cancerous cells. This phenomenon is similar to T cell exhaustion but less characterized, limiting therapeutic interventions. As shown for T cells, NK cells often display an increased expression of immune checkpoint proteins (ICP) following chronic stimulation, and ICP blockade therapies are currently being explored for several cancer types, with remarkable patient benefits. Nevertheless, the nature of ICP expression in NK cells is still poorly documented. In this study, we aimed to identify the conditions that lead to and the phenotype of immune checkpoint LAG3-expressing NK cells. Using various experimental models, we found that LAG3 is expressed by murine NK cells upon activation in different contexts, including in response to cancer and acute viral infections. LAG3 marks a subset of immature, proliferating, and activated cells, which, despite activation, have a reduced capacity to respond to a broad range of stimuli. Further characterization also revealed that LAG3+ NK cells exhibit a transcriptional signature similar to that of exhausted CD8+ T cells. Taken together, our results support the use of LAG3 as a marker of dysfunctional NK cells across diverse chronic and acute inflammatory conditions.


Related Papers

No related papers found

Powered by citation graph analysis